Yang Zou

2.1k total citations
78 papers, 1.2k citations indexed

About

Yang Zou is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yang Zou has authored 78 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Endocrinology, Diabetes and Metabolism, 43 papers in Epidemiology and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yang Zou's work include Liver Disease Diagnosis and Treatment (38 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers) and Diet, Metabolism, and Disease (20 papers). Yang Zou is often cited by papers focused on Liver Disease Diagnosis and Treatment (38 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers) and Diet, Metabolism, and Disease (20 papers). Yang Zou collaborates with scholars based in China, Australia and Japan. Yang Zou's co-authors include Guotai Sheng, Maobin Kuang, Chong Hu, Yanjia Zhong, Song Lu, Guobo Xie, Nan Peng, Ruijuan Yang, Yu Meng and Ling Zhong and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Yang Zou

67 papers receiving 1.2k citations

Peers

Countries citing papers authored by Yang Zou

Since Specialization

Citations

This map shows the geographic impact of Yang Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Zou more than expected).

Fields of papers citing papers by Yang Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Zou. The network helps show where Yang Zou may publish in the future.

Co-authorship network of co-authors of Yang Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Zou. A scholar is included among the top collaborators of Yang Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Zou. Yang Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparing the impact of cumulative insulin resistance surrogates exposure on stroke: optimizing prevention strategies 2025 ·Lipids in Health and Disease ·(unknown), (unknown), Guotai Sheng, Hongyi Yang, Wei Wang, Yang Zou	0
2	Formulation Optimization of Sinomenine-Loaded Nanostructured Lipid Carriers Based on Molecular Dynamics Simulations and Evaluation of Pharmacological Efficacy in Rheumatoid Arthritis 2025 ·International Journal of Molecular Sciences ·Xiaojie Lin, (unknown), Yang Zou, (unknown), Jingying Li, Yong‐Fu Xiao, Jiahui Xu, Jixin Li, (unknown), (unknown)	0
3	Assessing the validity of METS-IR for predicting the future onset of diabetes: an analysis using time-dependent receiver operating characteristics 2024 ·BMC Endocrine Disorders ·Jiajun Qiu, (unknown), (unknown), Ruijuan Yang, Maobin Kuang, Guotai Sheng, Yang Zou	4
4	Role of IL-1 Family Cytokines IL-36, IL-37, IL-38 in Osteoarthritis and Rheumatoid Arthritis: A Comprehensive Review 2024 ·Journal of Inflammation Research ·Yuan Xu, Jingyan Wang, Yang Zou, (unknown), Meng Tian	9
5	Evaluating the Prognostic Value of Systemic Immune-Inflammatory Index in Patients with Acute Decompensated Heart Failure 2024 ·ESC Heart Failure ·Jiajun Qiu, (unknown), Maobin Kuang, Chao Wang, (unknown), (unknown), Guobo Xie, (unknown), Guotai Sheng, Yang Zou	5
6	Lipoprotein Combine Index as a Better Marker for NAFLD Identification Than Traditional Lipid Parameters 2024 ·Diabetes Metabolic Syndrome and Obesity ·Jiajun Qiu, Xin Huang, Maobin Kuang, Ruijuan Yang, (unknown), Guotai Sheng, Yang Zou	8
7	Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study 2024 ·BMC Endocrine Disorders ·(unknown), (unknown), Maobin Kuang, Chao Wang, Xin Huang, Guotai Sheng, Yang Zou	9
8	The newly proposed plasma-glycosylated hemoglobin A1c/High-Density lipoprotein cholesterol ratio serves as a simple and practical indicator for screening metabolic associated fatty liver disease: an observational study based on a physical examination population 2024 ·BMC Gastroenterology ·(unknown), Song Lu, (unknown), Maobin Kuang, Jiajun Qiu, Guotai Sheng, Yang Zou	5
9	The predictive significance of lipid accumulation products for future diabetes in a non-diabetic population from a gender perspective: an analysis using time-dependent receiver operating characteristics 2023 ·Frontiers in Endocrinology ·Jiajun Qiu, Maobin Kuang, Yang Zou, Ruijuan Yang, (unknown), Dingyang Liu, Guotai Sheng, Wei Wang	4
10	The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease 2023 ·Frontiers in Endocrinology ·Jiajun Qiu, Maobin Kuang, Ruijuan Yang, (unknown), (unknown), Guotai Sheng, Yang Zou	3
11	Assessing temporal differences in the predictive power of baseline TyG-related parameters for future diabetes: an analysis using time-dependent receiver operating characteristics 2023 ·Journal of Translational Medicine ·Maobin Kuang, Ruijuan Yang, Xin Huang, Chao Wang, Guotai Sheng, Guobo Xie, Yang Zou	33
12	Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis 2023 ·Journal of Translational Medicine ·Song Lu, (unknown), Maobin Kuang, Chong Hu, Xinghui Li, Huijian Yang, Guotai Sheng, Guobo Xie, Yang Zou	42
13	Assessing temporal differences of baseline body mass index, waist circumference, and waist-height ratio in predicting future diabetes 2023 ·Frontiers in Endocrinology ·Guotai Sheng, Jiajun Qiu, Maobin Kuang, Nan Peng, Guobo Xie, (unknown), Shuhua Zhang, Yang Zou	9
14	Evaluation of the value of conventional and unconventional lipid parameters for predicting the risk of diabetes in a non-diabetic population 2022 ·Journal of Translational Medicine ·Guotai Sheng, Maobin Kuang, Ruijuan Yang, Yanjia Zhong, (unknown), Yang Zou	52
15	Relationship between creatinine to body weight ratios and diabetes mellitus: A Chinese cohort study 2022 ·Journal of Diabetes ·(unknown), Yang Zou, (unknown), (unknown), Changchun Cao, Haofei Hu, Xinyu Wang	6
16	Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk 2022 ·Diabetes Metabolic Syndrome and Obesity ·Guotai Sheng, Dingyang Liu, Maobin Kuang, Yanjia Zhong, Shuhua Zhang, Yang Zou	88
17	Association of body mass index with risk of prediabetes in Chinese adults: A population‐based cohort study 2022 ·Journal of Diabetes Investigation ·(unknown), Yuanqing Liu, Ruijuan Yang, Maobin Kuang, Jiajun Qiu, Yang Zou	10
18	Remnant Cholesterol is an Independent Predictor of New-Onset Diabetes: A Single-Center Cohort Study 2021 ·Diabetes Metabolic Syndrome and Obesity ·Guobo Xie, Yanjia Zhong, Shuo Yang, Yang Zou	41
19	The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease 2021 ·Lipids in Health and Disease ·Guotai Sheng, Song Lu, (unknown), Nan Peng, Maobin Kuang, Yang Zou	126
20	The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese population 2021 ·Lipids in Health and Disease ·Guotai Sheng, Nan Peng, Chong Hu, Ling Zhong, (unknown), Yang Zou	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact